Results 181 to 190 of about 1,960,750 (298)

Lymphocyte transformation test in pediatric drug hypersensitivity: case series report from a tertiary care hospital. [PDF]

Front Immunol
Rogozina O, Martín-López S, Dueñas López FC, Del Solar Moreno Z, Leiva Castrejon L, Aguilar-Concepción D, Jiménez-González M, Martínez Feito A, González-Muñoz M, Ramírez E.   +9 more
europepmc   +1 more source

Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions. [PDF]

Front Genet, 2023
Manson LEN, Delwig SJ, Drabbels JJM, Touw DJ, De Vries APJ, Roelen DL, Guchelaar HJ.   +6 more
europepmc   +1 more source

Operationalizing Precision Medicine in Drug Development: Predictive Biomarkers, Companion Diagnostics, and Regulatory Pathways

Clinical Pharmacology &Therapeutics, EarlyView.
Precision medicine offers the opportunity to improve the benefit–risk profile of new therapies by prospectively identifying patients most likely to respond or least likely to experience harm; however, its systematic integration into drug development remains inconsistent outside oncology.
Ingrid Holst‐Laubjerg, José M.A. Moreira   +1 more
wiley   +1 more source

Drug-induced cutaneous hypersensitivity vasculitis [PDF]

Journal of Clinical and Scientific Research, 2016
Harikrishna J, Surekha A, Kalyana Chakravarthy DP, Sreevidya B   +3 more
doaj   +1 more source

Drug hypersensitivity leading to emergency department visit: a comprehensive analysis of clinical features and management. [PDF]

Korean J Intern Med
Chung SJ, Kim NY, Kim SJ, Kim J, Park HA, Choi JH.   +5 more
europepmc   +1 more source

CNS tuberculoma in an immunocompetent patient: A case report of multi-drug hypersensitivity to RIPE therapy. [PDF]

IDCases, 2023
Huber B, Joshi S.
europepmc   +1 more source

Early and High‐Dose Glucocorticoid Use and Survival in Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Multicenter Target Trial Emulation

Clinical Pharmacology &Therapeutics, EarlyView.
Despite the immunomodulatory mechanism of immune checkpoint inhibitors (ICIs), systemic glucocorticoids are commonly used in advanced non–small cell lung cancer (NSCLC). Evidence regarding their effects on ICI outcomes is inconsistent, in part due to confounding by indication and immortal time bias.
Da Eun Lee, Geunho Lim, Minoh Ko, Mari Kim, Ji Sun Chun, Borim Lee, Miso Kim, Kwangsoo Kim, Byung Kwan Choi, Jeongmin Seo, Jin Hyoung Kang, Taehoon Ko, In‐Wha Kim, Jung Mi Oh   +13 more
wiley   +1 more source

Clinical Spectrum of Drug Hypersensitivity Reactions in Systemic Mastocytosis: Drug-Induced Anaphylaxis as a Unique Clinical Presentation. [PDF]

Medicina (Kaunas)
Aslan E, Okan K, Kural RF, İnan S, Özeke Y, Ateş Ü, Yıldırım O, Galata Z, Kırdök K, Ay E, Dizdar Canbaz T, Toksoy Şentürk Mİ, Karaaslan Yetemen S, Gümüşburun R, Akten HS, Aytaç H, Özışık M, Çamyar A, Demiroğlu G, Bulut G, Demir M, Soyer N, Keklik Karadağ F, Demir D, Hekimgil M, Özsan N, Şarer Yürekli BP, Karaca E, Durmaz MB, Tunakan Dalgıç C, Kokuludağ A, Sin AZ, Mete Gökmen EN.   +32 more
europepmc   +1 more source

Clinical Significance of Acute Kidney Injury in Idiosyncratic Drug‐Induced Liver Injury: A Multicentric Propensity Scores Matched Study

Clinical Pharmacology &Therapeutics, EarlyView.
Clinical significance of acute kidney injury in idiosyncratic drug‐induced liver injury: a multicentric propensity scores matched study. Evidence about the role of acute kidney injury (AKI) in idiosyncratic drug‐induced liver injury (DILI) is still scarce.
José María Pinazo‐Bandera, Hao Niu, Juan Pedro Toro‐Ortiz, Inmaculada Medina‐Caliz, Judith Sanabria‐Cabrera, Aída Ortega‐Alonso, Mercedes Robles‐Díaz, Daniel Enrique Di Zeo‐Sanchez, Nelia Hernández, Fernando Bessone, Vinicius Nunes, Raymundo Paraná, M. Isabel Lucena, Raul J. Andrade, Ismael Alvarez‐Alvarez, Miren García‐Cortés   +15 more
wiley   +1 more source

Unveiling the Uncommon: A Rare IgE-Mediated Presentation of Multiple Drug Hypersensitivity Syndrome. [PDF]

Cureus
Soares AV, Mota D, Brandão Abreu D, Dias-Castro E, Carneiro-Leão L.   +4 more
europepmc   +1 more source